Several clinical measures of disease activity in patients with systemic lupus erythematosus (SLE) have been proposed, but it is unclear which of these most accurately reflects SLE activity and which is most sensitive to change. The degree of change in SLE activity that patients consider important is also unknown. This prospective longitudinal study will determine the relative accuracy and relative sensitivity to change of five SLE activity measures (the Systemic Lupus Activity Measure, the Systemic Lupus Erythematosus Disease Activity Group index, and the European Consensus Lupus Activity Measurement), and will determine the importance to patients of changes in SLE activity. Sixty patients with active SLE will be examined every two weeks for 40 weeks. At each assessment, SLE activity will be scored using each of the five SLE activity measures, physician global assessments of SLE activity will be recorded, and patients will judge the importance of interval changes in SLE activity. The accuracy of the SLE activity measures will be evaluated by comparing the extent to which changes in different measures correlate with each other over time (i.e. longitudinal construct validity). Sensitivity to change will be estimated using standardized response means, calculated for each SLE activity measure for the time period of most rapid change in clinical status in each patient. Changes considered important with a high degree of specificity will be identified using receiver operating characteristic curves. The most useful measure for assessing patients with SLE would be that which is both most accurate and sensitive to change. Identifying the degree of change in SLE activity that patients commonly consider important would provide a guide by which to judge the value of specific treatments.

Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Ward, M M; Marx, A S; Barry, N N (2002) Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology (Oxford) 41:184-8
Lubeck, D P (2001) A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics 19:811-8
Ward, M M; Marx, A S; Barry, N N (2000) Identification of clinically important changes in health status using receiver operating characteristic curves. J Clin Epidemiol 53:279-84
Ward, M M; Marx, A S; Barry, N N (2000) The rating scale preference measure as an evaluative measure in systemic lupus erythematosus. Lupus 9:696-701
Ward, M M; Marx, A S; Barry, N N (2000) Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 27:664-70
Calkins, H; Yong, P; Miller, J M et al. (1999) Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 99:262-70
Fischer, D; Stewart, A L; Bloch, D A et al. (1999) Capturing the patient's view of change as a clinical outcome measure. JAMA 282:1157-62
van Vollenhoven, R F; Park, J L; Genovese, M C et al. (1999) A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 8:181-7
Ward, M M; Lubeck, D; Leigh, J P (1998) Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings. J Rheumatol 25:641-9
Hsieh, F Y; Bloch, D A; Larsen, M D (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17:1623-34

Showing the most recent 10 out of 47 publications